Paradigm Biopharmaceuticals Limited Stock
Stocks
PAR
AU000000PAR5
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1750 AUD | +6.06% |
|
+6.06% | -48.53% |
| Market Cap | 104M 72.74M 63.22M 59.02M 54.18M 102M 6.93B 696M 273M 3.46B 273M 267M 11.4B | P/E 2026 * |
-1.91x | P/E 2027 * | -2.11x |
|---|---|---|---|---|---|
| Enterprise Value | 69.95M 48.95M 42.54M 39.72M 36.46M 68.75M 4.67B 468M 183M 2.33B 184M 180M 7.67B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.43% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +6.06% | ||
| 1 week | +6.06% | ||
| Current month | +6.06% | ||
| 1 month | +2.94% | ||
| 3 months | +9.38% | ||
| 6 months | -40.68% | ||
| Current year | -48.53% |
| 1 week | 0.16 |  | 0.18 |
| 1 month | 0.16 | | 0.18 |
| Current year | 0.14 | | 0.37 |
| 1 year | 0.14 | | 0.47 |
| 3 years | 0.14 | | 0.9 |
| 5 years | 0.14 | | 2.69 |
| 10 years | 0.14 | | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CEO | Chief Executive Officer | - | 2022-11-21 |
Abby Macnish
DFI | Director of Finance/CFO | - | 2023-03-02 |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Rennie
CHM | Chairman | - | - |
Amos Meltzer
BRD | Director/Board Member | 60 | 2020-12-08 |
Matthew Fry
BRD | Director/Board Member | - | 2024-03-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/23/26 | Expiration | Chief Executive Officer | 50,000 | 0.0115% | ||
| 2/23/26 | Expiration | Director | 354,958 | 0.0819% | ||
| 2/23/26 | Expiration | Chief Executive Officer | 2,691,961 | 0.6210% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.06% | +6.06% | -49.28% | -80.87% | 68.8M | |
| -0.36% | +0.14% | -0.95% | +14.33% | 48.53B | |
| -2.43% | -2.45% | +393.44% | +475.29% | 39.87B | |
| -0.62% | +8.86% | +27.01% | +7.31% | 38.68B | |
| -1.51% | -4.66% | +2.11% | +50.96% | 35.13B | |
| -2.41% | +2.59% | +11.68% | +41.16% | 29.79B | |
| +0.23% | -2.65% | +32.67% | +122.34% | 16.11B | |
| +0.40% | -4.11% | - | - | 16.08B | |
| -0.62% | +1.23% | +1.80% | +15.05% | 13.61B | |
| -2.57% | -7.17% | -4.93% | -37.59% | 12.62B | |
| Average | -0.61% | +0.77% | +45.95% | +67.55% | 25.05B | |
| Weighted average by Cap. | -1.26% | +1.82% | +75.05% | +105.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -36.3M -25.4M -22.08M -20.61M -18.92M -35.68M -2.42B -243M -95.19M -1.21B -95.42M -93.3M -3.98B | -44.8M -31.35M -27.25M -25.44M -23.35M -44.03M -2.99B -300M -117M -1.49B -118M -115M -4.92B |
| Net Debt | -34M -23.79M -20.68M -19.31M -17.72M -33.42M -2.27B -228M -89.15M -1.13B -89.37M -87.39M -3.73B | -12M -8.4M -7.3M -6.81M -6.26M -11.79M -800M -80.34M -31.47M -399M -31.54M -30.84M -1.32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | A$0.1750 | +6.06% | 1,468,713 |
| 26-07-31 | A$0.1650 | +3.13% | 873,561 |
| 26-07-30 | A$0.1600 | -3.03% | 1,466,351 |
| 26-07-29 | A$0.1650 | 0.00% | 2,026,994 |
| 26-07-28 | A$0.1650 | -2.94% | 613,971 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- PAR Stock
Select your edition
All financial news and data tailored to specific country editions
